MIVT Announces Excellent Results in Studies of Stent Coatings

MIV Therapeutics (MIVT), a developer of next-generation biocompatible stent coatings and drug delivery technologies, announced it received encouraging reports from independent researchers evaluating the company's novel multiplatform/multidrug delivery solution in short-term animal studies.

PharmaLive (http://www.pharmalive.com/News/index.cfm?articleid=231991&categoryid=40)